中牧股份(600195.SH):蘭州廠的相關獸用疫苗產品批准文號被註銷及撤銷
格隆匯1月15日丨中牧股份(600195.SH)公佈,2020年1月15日,農業農村部發布第259號公告,決定依法撤銷公司所屬分支機構蘭州生物藥廠(“蘭州廠”)的布氏菌病活疫苗(A19株)和布氏菌病活疫苗(S2株)產品批准文號獸藥生字280017010、獸藥生字280017011;註銷蘭州廠豬丹毒活疫苗(G4T10株),豬瘟耐熱保護劑活疫苗(細胞源),豬多殺性巴氏桿菌病滅活疫苗(C44-1株),牛多殺性巴氏桿菌病滅活疫苗,山羊痘活疫苗,山羊傳染性胸膜肺炎滅活疫苗(山羊支原體山羊肺炎亞種C87001株),羊快疫、猝狙、羔羊痢疾、腸毒血癥三聯四防滅活疫苗,共7個獸藥產品批准文號。公司現就有關情況説明如下:
上述產品均為蘭州廠布魯氏菌病疫苗生產車間生產的疫苗產品,2018年上述產品實現營業收入918.34萬元,佔蘭州廠營業收入的比例為1.62%,上述產品毛利額為-149.74萬元。
蘭州廠布魯氏菌病疫苗生產車間關停及其對公司的影響,詳見公司於2020年1月15日披露的《中牧實業股份有限公司關於蘭州生物藥廠獸用布魯氏菌病疫苗車間整改進展情況的公告》。
蘭州廠除布魯氏菌病疫苗生產車間關停外,其他疫苗產品均正常生產。蘭州廠生產區整體搬遷項目正如期推進,公司將加強項目建設的質量、進度、預算和安全監督管理,做好生產運營的各項準備,保障新舊工廠生產經營的連續性和穩定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.